Výsledky vyhledávání - "Helle Wohlleben"

High expression of cystine–glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma

Autor: Christoph P. Beier, Helle Wohlleben, Bjarne Winther Kristensen, Sólborg Berglind Heimisdóttir, Casper Schau Mellegaard, Mia D. Sørensen, Mai Froberg Sørensen

Publikováno v: Sørensen, M F, Heimisdóttir, S B, Sørensen, M D, Mellegaard, C S, Wohlleben, H, Kristensen, B W & Beier, C P 2018, ' High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma ', Journal of Neuro-Oncology, vol. 138, no. 1, pp. 49–53 . https://doi.org/10.1007/s11060-018-2785-9

Epileptic seizures are an important cause of morbidity in glioma patients. Substantial lines of evidence support the concept of the excitatory neurotransmitter glutamate being a crucial mediator of glioma-associated seizures. In gliomas, non-vesicula

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4e6fc51c18081c34a3e24abd508921f
https://doi.org/10.1007/s11060-018-2785-9

Zobrazit plný text záznamu

High levels of c-Met is associated with poor prognosis in glioblastoma

Autor: Helle Wohlleben, Rikke Hedegaard Dahlrot, Stine Asferg Petterson, Christoph P. Beier, Michael Tveden Gundesen, Steinbjørn Hansen, Tine Rasmussen, Sune Munthe, Simon Kjær Hermansen, Bjarne Winther Kristensen

Publikováno v: Petterson, S A, Dahlrot, R H, Hermansen, S K, K A Munthe, S, Gundesen, M T, Wohlleben, H, Rasmussen, T, Beier, C P, Hansen, S & Kristensen, B W 2015, ' High levels of c-Met is associated with poor prognosis in glioblastoma ', Journal of Neuro-Oncology, vol. 122, no. 3, pp. 517-527 . https://doi.org/10.1007/s11060-015-1723-3

The tyrosine kinase receptor c-Met has been suggested to be involved in crucial parts of glioma biology like tumor stemness, growth and invasion. The aim of this study was to investigate the prognostic value of c-Met in a population-based glioma pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fc233834e7a4f301cd9a2d3968d143e
https://doi.org/10.1007/s11060-015-1723-3

Zobrazit plný text záznamu

High Expression of Cystine-Glutamate antiporter XCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma

Autor: Christoph Patrick Beier, Sólborg Berglind Heimisdóttir, Helle Wohlleben, Bjarne Winther Kristensen

Publikováno v: Beier, C P, Berglind Heimisdóttir, S, Wohlleben, H & Kristensen, B W 2017, ' High Expression of Cystine-Glutamate antiporter XCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma ', CT 32nd International Epilepsi Congress, Barcelona, Spain, 02/09/2017-06/09/2017 .
University of Southern Denmark

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::849a871c9651123cd8da917f26bf1f9a
https://portal.findresearcher.sdu.dk/da/publications/375fdccb-fd5c-41e5-a38b-c3aa083d67d8

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání